JP2017501749A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501749A5
JP2017501749A5 JP2016563876A JP2016563876A JP2017501749A5 JP 2017501749 A5 JP2017501749 A5 JP 2017501749A5 JP 2016563876 A JP2016563876 A JP 2016563876A JP 2016563876 A JP2016563876 A JP 2016563876A JP 2017501749 A5 JP2017501749 A5 JP 2017501749A5
Authority
JP
Japan
Prior art keywords
host cell
ornithine
recombinant protein
culture medium
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016563876A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501749A (ja
JP6732660B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/069378 external-priority patent/WO2015105609A1/en
Publication of JP2017501749A publication Critical patent/JP2017501749A/ja
Publication of JP2017501749A5 publication Critical patent/JP2017501749A5/ja
Application granted granted Critical
Publication of JP6732660B2 publication Critical patent/JP6732660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016563876A 2014-01-13 2014-12-09 組換えタンパク質の高マンノースグリコフォーム含有量を操作するためのオルニチン代謝の調節 Active JP6732660B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461926481P 2014-01-13 2014-01-13
US61/926,481 2014-01-13
PCT/US2014/069378 WO2015105609A1 (en) 2014-01-13 2014-12-09 Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins

Publications (3)

Publication Number Publication Date
JP2017501749A JP2017501749A (ja) 2017-01-19
JP2017501749A5 true JP2017501749A5 (https=) 2017-12-07
JP6732660B2 JP6732660B2 (ja) 2020-07-29

Family

ID=52273554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016563876A Active JP6732660B2 (ja) 2014-01-13 2014-12-09 組換えタンパク質の高マンノースグリコフォーム含有量を操作するためのオルニチン代謝の調節

Country Status (14)

Country Link
US (2) US10513723B2 (https=)
EP (1) EP3094735A1 (https=)
JP (1) JP6732660B2 (https=)
KR (1) KR102381791B1 (https=)
CN (2) CN106029896B (https=)
AU (3) AU2014376225C1 (https=)
BR (2) BR122020004385B1 (https=)
CA (1) CA2936104C (https=)
CL (3) CL2016001786A1 (https=)
EA (2) EA039141B1 (https=)
IL (1) IL246727B (https=)
MX (2) MX384153B (https=)
SG (2) SG10201806643WA (https=)
WO (1) WO2015105609A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
TWI870789B (zh) 2015-08-04 2025-01-21 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
BR112020000127A2 (pt) * 2017-07-06 2020-07-07 Regeneron Pharmaceuticals, Inc. método para selecionar um hidrolisado de soja, e, glicoproteína
RU2672318C1 (ru) * 2017-09-19 2018-11-13 Общество с ограниченной ответственностью "Международный Биотехнологический Центр "Генериум" Способ получения моноклональных антител терапевтического назначения с помощью непрерывного культивирования клеток сно
AU2018392658B2 (en) 2017-12-20 2024-07-25 Ares Trading S.A. Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
CN111671051B (zh) * 2020-07-30 2022-01-11 广州同康生物科技有限公司 一种整粒黄豆中嘌呤的脱除工艺

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP0939121B2 (de) 1989-09-12 2007-12-26 AHP Manufacturing B.V. TFN-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
PT672141E (pt) 1992-10-23 2003-09-30 Immunex Corp Metodos de preparacao de proteinas oligomericas soluveis
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
US5721121A (en) 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
DK1666591T3 (da) 1995-06-29 2011-05-23 Immunex Corp Cytokin der inducerer apoptose
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
CN101255192A (zh) 2000-05-26 2008-09-03 布里斯托尔-迈尔斯斯奎布公司 可溶性ctla4突变体分子及其应用
US20030104996A1 (en) * 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
US20070190057A1 (en) * 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
WO2008154014A2 (en) * 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
PT2837680T (pt) 2011-07-01 2020-04-17 Amgen Inc Cultura celular de mamífero

Similar Documents

Publication Publication Date Title
JP2017501749A5 (https=)
JP2017538446A5 (https=)
AR132549A2 (es) Medio de cultivo para células cho libre de suero que comprende ornitina y putrescina, método para cultivar células cho y método in vitro para producir una proteína
IL310968B2 (en) Mammalian cell culture
ES2705206T3 (es) Método de producción de un polipéptido o virus de interés en un cultivo celular continuo
IL310186B1 (en) Plasma kallikrein binding proteins
BRPI0714347A2 (pt) processo aperfeiÇoado para o cultivo de cÉlulas
JP2019514411A5 (https=)
JP6998853B2 (ja) 凝集方法
Hirt et al. Trichomonas vaginalis pathobiology: new insights from the genome sequence
BR112013025086A2 (pt) sistema e métodos de biorreator multifuncional para classificação e cultura de células
JP2015521848A5 (https=)
JP2015507921A5 (https=)
JP2011188872A5 (https=)
JP2013533745A5 (https=)
PH12015501837B1 (en) Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins
CN110520538A (zh) 灌注培养基
JP2014100148A5 (https=)
JP2012065652A5 (https=)
JP2015531241A5 (https=)
JP2015532096A5 (https=)
CN105189739A (zh) 生产腺病毒的方法
JP2019500876A5 (https=)
NZ622731A (en) Increasing virus-like particle yield in plants
Buyl et al. The impact of cell-expansion and inflammation on the immune-biology of human adipose tissue-derived mesenchymal stromal cells